Paper2249186
Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial.
Gaynon PS and 5 others. Cancer, 1990. Cited by 130 papers, by iCite.
Cite this record
ConductScience Library. Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial. Papers, record 2249186. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2249186
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Carboplatin | Major topic |
| Adolescent | |
| Adult | |
| Astrocytoma | |
| Cerebellar Neoplasms | |
| Child | |
| Child, Preschool | |
| Drug Evaluation | |
| Ependymoma | |
| Female | |
| Glioma | |
| Humans | |
| Infant | |
| Male | |
| Medulloblastoma |
Source PubMed
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 130 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42016022 | CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas. | Neurooncol Adv | 2026 | https://conductscience.org/library/papers/42016022 | PubMed |
| 34065991 | Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34065991 | PubMed |
| 32547627 | Temozolomide and oral etoposide in children with recurrent malignant brain tumors. | Drugs Context | 2020 | https://conductscience.org/library/papers/32547627 | PubMed |
| 30332335 | Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial. | J Clin Oncol | 2018 | https://conductscience.org/library/papers/30332335 | PubMed |
| 26842817 | Craniospinal irradiation with concomitant and adjuvant temozolomide--a feasibility assessment of toxicity in patients with glioblastoma with a PNET component. | J Neurooncol | 2016 | https://conductscience.org/library/papers/26842817 | PubMed |
| 26403167 | CNS Anticancer Drug Discovery and Development Conference White Paper. | Neuro Oncol | 2015 | https://conductscience.org/library/papers/26403167 | PubMed |
| 25704363 | Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology Group. | Pediatr Blood Cancer | 2015 | https://conductscience.org/library/papers/25704363 | PubMed |
| 24117271 | Ependymomas: development of immunotherapeutic strategies. | Expert Rev Neurother | 2013 | https://conductscience.org/library/papers/24117271 | PubMed |
| 23748464 | Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients. | Childs Nerv Syst | 2013 | https://conductscience.org/library/papers/23748464 | PubMed |
| 22942186 | Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. | Neuro Oncol | 2012 | https://conductscience.org/library/papers/22942186 | PubMed |
| 22798016 | Current treatment options for pediatric and adult patients with ependymoma. | Curr Treat Options Oncol | 2012 | https://conductscience.org/library/papers/22798016 | PubMed |
| 22665539 | Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/22665539 | PubMed |
| 22641364 | Paediatric and adult malignant glioma: close relatives or distant cousins? | Nat Rev Clin Oncol | 2012 | https://conductscience.org/library/papers/22641364 | PubMed |
| 21788981 | Childhood brain tumors: epidemiology, current management and future directions. | Nat Rev Neurol | 2011 | https://conductscience.org/library/papers/21788981 | PubMed |
| 20297854 | Childhood medulloblastoma: current status of biology and treatment. | CNS Drugs | 2010 | https://conductscience.org/library/papers/20297854 | PubMed |
| 20111585 | Antiangiogenic therapy in the treatment of recurrent medulloblastoma in the adult: case report and review of the literature. | J Oncol | 2009 | https://conductscience.org/library/papers/20111585 | PubMed |
| 19458954 | The history of ependymoma management. | Childs Nerv Syst | 2009 | https://conductscience.org/library/papers/19458954 | PubMed |
| 19360417 | Salvage chemotherapy for metastatic and recurrent ependymoma of childhood. | Childs Nerv Syst | 2009 | https://conductscience.org/library/papers/19360417 | PubMed |
| 19212772 | New chemotherapy strategies and biological agents in the treatment of childhood ependymoma. | Childs Nerv Syst | 2009 | https://conductscience.org/library/papers/19212772 | PubMed |
| 19117350 | Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors. | Cancer | 2009 | https://conductscience.org/library/papers/19117350 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2249186
GET https://conductscience.org/api/papers/v1/2249186/cited_by?page=2